Irvine, CA, United States of America

Joseph G Vehige

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Newport Coast, CA (US) (2020)
  • Irvine, CA (US) (2021 - 2023)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Joseph G. Vehige: Innovator in Ophthalmic and Dermatologic Treatments

Introduction

Joseph G. Vehige is a prominent inventor based in Irvine, California, known for his significant contributions to the field of ophthalmology and dermatology. With a total of eight patents to his name, he has made remarkable advancements in the treatment and prevention of various ocular surface conditions.

Latest Patents

Among his latest patents, Joseph has developed isoxazoline parasiticide formulations. These compositions are designed for treating or preventing ophthalmic and dermatologic conditions in human subjects. They include targeted local activity for ocular surface conditions such as blepharitis and rosacea. The formulations can be topically administered directly to the eye, eyelid, or eyelashes of the patient. Additionally, he has disclosed methods for administering these compositions effectively to patients in need of treatment.

Career Highlights

Joseph G. Vehige has established a successful career at Tarsus Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceuticals. His work focuses on developing effective treatments that enhance patient care and improve health outcomes.

Collaborations

Joseph has collaborated with notable colleagues, including Bobak Robert Azamian and Douglas Michael Ackermann, Jr. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Joseph G. Vehige's contributions to ophthalmic and dermatologic treatments through his innovative patents highlight his dedication to improving patient care. His work at Tarsus Pharmaceuticals, Inc. continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…